974. Real World Experience of Posaconazole Therapeutic Drug Monitoring in Oncology Patients: Clinical Implications of Hypoalbuminemia as a Predictor of Subtherapeutic Posaconazole Levels

BACKGROUND: Posaconazole (POS) is utilized for prophylaxis or treatment of invasive fungal infections (IFI) in patients with malignancies or following stem cell transplant (SCT). Subtherapeutic levels may be associated with breakthrough infection and therapeutic drug monitoring (TDM) is recommended....

Descripción completa

Detalles Bibliográficos
Autores principales: Pasikhova, Yanina, Greene, John, Morrison, Austin R, Handley, Guy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679155/
http://dx.doi.org/10.1093/ofid/ofad500.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679155/
http://dx.doi.org/10.1093/ofid/ofad500.029

Ejemplares similares